Secondly, following ICI MAb-mediated targeting of CTLA4-/PD-1-expressing Tregs, effective recovery of anti-tumor immunity, and possibly development of IRAEs, appears to be dependent on a gut microbiota populated with commensal microorganisms conducive to immune system re-programming (75–86, 88–90). The gene discussed is CTLA4; the disease is neoplasm.